Welcome to GSKPro UK

For UK healthcare professionals - information on GSK's medicines and vaccines, educational resources and more.
I’m a UK healthcare professional

Important notice: this site is intended for UK healthcare professionals. By entering this site, you are confirming that you are a UK healthcare professional. Excluding the Medical Affairs section, this site contains promotional information.

I’m a member of the UK public

This site is intended for members of the UK public, patients and their carers.

December 2024 | PM-GB-NA-WCNT-240001 (V2.0)
GSK Logo

For UK Healthcare professionals

DNA

Webshop

Support your patients and practice with these healthcare resources. Delivery is free on all orders.

Relevant Prescribing Information is available below within resource boxes. Adverse Event reporting statement can be found at the bottom of this page.

Login to order
Filter
Product
COPD Action Planner Booklet
 Physical
July 2026 | PM-GB-RS-WCNT-250003 (V2.0)
COPD Action Planner Booklet
Component of Trelegy Ellipta (fluticasone furoate/ umeclidinium/ vilanterol) Patient Support Pack
Prescribing Information
COPD Psychology of Behaviour Change Booklet
 Physical
July 2026 | PM-GB-RS-WCNT-250004 (V2.0)
COPD Psychology of Behaviour Change Booklet
Component of Trelegy Ellipta (fluticasone furoate/ umeclidinium/ vilanterol) Patient Support Pack
Prescribing Information
COPD Action Planner REFILL:
 Physical
July 2026 | PM-GB-RS-WCNT-250002 (V2.0)
COPD Symptom Tracker Booklet
Component of Trelegy Ellipta (fluticasone furoate/ umeclidinium/ vilanterol) Patient Support Pack
Prescribing information
COPD Symptom Tracker REFILL
 Physical
July 2026 | PM-GB-RS-WCNT-250006 (V2.0)
COPD Symptom Tracker REFILL
Component of Trelegy Ellipta (fluticasone furoate/ umeclidinium/ vilanterol) Patient Support Pack
Prescribing Information
Digital Desktop COPD Action Planner
 Digital
April 2026 | PM-GB-RS-WCNT-260004 (V1.0)
Digital Desktop COPD Action Planner
Component of Trelegy Ellipta (fluticasone furoate/ umeclidinium/ vilanterol) Patient Support Pack
Prescribing Information
Digital Desktop COPD Symptom Tracker
 Digital
April 2026 | PM-GB-RS-WCNT-260005 (V1.0)
Digital Desktop COPD Symptom Tracker
Component of Trelegy Ellipta (fluticasone furoate/ umeclidinium/ vilanterol) Patient Support Pack
Prescribing Information
Digital Mobile COPD Action Planner
 Digital
April 2026 | PM-GB-RS-WCNT-260003 (V1.0)
Digital Mobile COPD Action Planner
Component of Trelegy Ellipta (fluticasone furoate/ umeclidinium/ vilanterol) Patient Support Pack
Prescribing Information
Digital Mobile COPD Symptom Tracker
 Digital
April 2026 | PM-GB-RS-WCNT-260006 (V1.0)
Digital Mobile COPD Symptom Tracker
Component of Trelegy Ellipta (fluticasone furoate/ umeclidinium/ vilanterol) Patient Support Pack
Prescribing Information
Ellipta demonstration device
 Physical
May 2026 | PM-GB-RS-WCNT-200028 (v3.0)
Ellipta demonstration device
Demonstration device for healthcare professionals to show patients how to use the Ellipta device correctly.
Prescribing Information
Ellipta Inhalation Trainer
 Physical
May 2026 | PM-GB-RS-WCNT-200035 (v4.0)
Ellipta Inhalation Trainer
Training whistle that helps patients understand the correct inspiratory flow needed to use the Ellipta device.
Prescribing Information
Nucala (mepolizumab) for COPD: Patient information booklet
 Physical
July 2026 | PM-GB-MPL-WCNT-260013
Nucala (mepolizumab) for COPD: Patient information booklet
For patients with COPD, prescribed Nucala 100 mg prefilled syringe/pen.
Prescribing Information
Nucala (mepolizumab) for COPD: patient information booklet
 Digital
July 2026 | PM-GB-MPL-WCNT-260016
Nucala (mepolizumab) for COPD: Patient information booklet (Digital)
For patients with COPD, prescribed Nucala 100 mg prefilled syringe/pen.
Prescribing Information
Nucala (mepolizumab) patient information booklet
 Physical
July 2026 | PM-GB-MPL-WCNT-260006 (V2.0)
Nucala (mepolizumab) patient information booklet
For patients with severe refractory eosinophilic asthma, prescribed Nucala 100 mg prefilled syringe/pen.
Prescribing Information
Nucala (mepolizumab) Pre-filled pen demo device
 Physical
July 2026 | PM-GB-MPL-WCNT-220008 (V4.0)
Nucala (mepolizumab) Pre-filled pen demo device
Demonstration device for healthcare professionals to show patients how to use the pre-filled pen.
Prescribing Information
Nucala (mepolizumab) Pre-filled syringe demo device
 Physical
July 2026 | PM-GB-MPL-WCNT-220004 (V4.0)
Nucala (mepolizumab) Pre-filled syringe demo device
Demonstration device for healthcare professionals to show patients how to use the pre-filled syringe.
Prescribing Information
Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) Patient Support Pack
 Physical
July 2026 | PM-GB-RS-WCNT-240010 (V2.0)
Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) Patient Support Pack
Support pack for patients who have been prescribed Trelegy Ellipta
Prescribing Information

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellowcard in the Google Play or Apple App Store. Adverse events should also be reported to GSK on 0800 221 441 or UKSafety@gsk.com.

December 2024 | PM-GB-NA-WCNT-240001 (V2.0)

GSK Logo

© 2020-2024 GSK group of companies. All rights reserved. Trade marks are owned by or licensed to the GSK group of companies. GlaxoSmithKline UK Limited Registered in England and Wales No 4310159. Registered office: 79 New Oxford Street, London, United Kingdom, WC1A 1DG.